These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Telaprevir use in a chronic hepatitis C patient with hemophilia. Guner R, Tufan ZK. Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):248. PubMed ID: 24366457 [No Abstract] [Full Text] [Related]
3. Anti-HCV agent, ribavirin, elevates the activity of clotting factor VII in patients with hemophilia: a possible mechanism of decreased events of bleeding in patients with hemophilia by ribavirin. Yamamoto K, Honda T, Matsushita T, Kojima T, Takamatsu J. J Thromb Haemost; 2006 Feb; 4(2):469-70. PubMed ID: 16420581 [No Abstract] [Full Text] [Related]
4. Should treatment of hepatitis C in HIV-seropositive and HIV-seronegative patients with hemophilia include induction doses of interferon? McGovern B, Bica I. Clin Infect Dis; 2003 Aug 01; 37(3):463-4; author reply 464-5. PubMed ID: 12884180 [No Abstract] [Full Text] [Related]
7. Up to date treatment of hepatitis C in adults. Schalm SW, Brouwer JT. Acta Gastroenterol Belg; 1998 Aug 01; 61(4):397-9. PubMed ID: 9923088 [No Abstract] [Full Text] [Related]
8. [Treatment of chronic hepatitis C in special groups]. Bourlière M, Halfon P, Portal I. Gastroenterol Clin Biol; 2002 Apr 01; 26 Spec No 2():B238-47. PubMed ID: 12180296 [No Abstract] [Full Text] [Related]
9. [Treatment of chronic hepatitis C. Combined treatment in naive patients]. Forns Bernhardt X. Gastroenterol Hepatol; 2000 Feb 01; 23 Suppl 1():43-6. PubMed ID: 11968343 [No Abstract] [Full Text] [Related]
11. Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin. Alavian SM, Tabatabaei SV. Eur J Gastroenterol Hepatol; 2010 Jan 01; 22(1):123-4. PubMed ID: 19959942 [No Abstract] [Full Text] [Related]
13. Effect of ribavirin, in combination with interferon in patients with hepatitis C, on the bleeding risk associated with selective serotonin reuptake inhibitors. Honda T, Katano Y, Toyoda H, Hayashi K, Ishigami M, Nakano I, Goto H, Yamamoto K, Takamatsu J. J Clin Psychiatry; 2008 Apr 01; 69(4):679-80. PubMed ID: 18507491 [No Abstract] [Full Text] [Related]
15. [Treatment of chronic hepatitis C in patients without previous treatment]. Dehesa Violante M. Rev Gastroenterol Mex; 2002 Oct 01; 67 Suppl 2():S42-4. PubMed ID: 12712852 [Abstract] [Full Text] [Related]
16. Patterns of response during therapy with interferon and outcome of retreatment with interferon plus ribavirin for chronic hepatitis C. Ogana G, Tocco A, Garrucciu G, Branca B, Azara V, Manzoni NE, Deplano A, Solinas A. J Clin Gastroenterol; 2001 Sep 01; 33(3):254-5. PubMed ID: 11500622 [No Abstract] [Full Text] [Related]
17. Re: Khalili et al.--chronic Hepatitis C treatment in interferon nonresponders. Glaser D. Am J Gastroenterol; 2000 Nov 01; 95(11):3315-6. PubMed ID: 11095370 [No Abstract] [Full Text] [Related]
18. An emerging role for interferon in haemophiliacs with chronic hepatitis C? Aguilar C, Lucia JF, Simón MA. Haemophilia; 2001 Jan 01; 7(1):6-8. PubMed ID: 11136373 [Abstract] [Full Text] [Related]